Your search matched 65 results
In some rooms at Cedars-Sinai Hospital, patients won’t spend a moment alone—sort of—now that the leading Beverly Hills medical center has partnered with Aiva Health to make select rooms smart.
While the term “micro-influencer” may still sound to you like some flippant, gen-Z farce, the side hustle cum way of life just scored serious validation.
Is the market prepared for DTx?
Digital health company Peerwell created an app to prepare patients for surgery and, in turn, reduce the amount of time they spend in the hospital.
At this year’s Digital Medicine & MedTech Showcase (part of Biotech Showcase), a panel of digital therapeutics (DTx) experts illuminated the status and future of their work, moderated by Syneos Health Commercial Solutions Chief Strategy Officer, Baba Shetty.
With there being so many different stakeholders, including patients, providers and payers, panelists at the 2019 Digital Medicine & MedTech Showcase pointed to a number of different adoption roadblocks—and successes.
F.D.A. | Blog
An expert panel that advises U.S. federal regulatory authorities has recommended approval of Esketamine, Johnson & Johnson’s brand-new treatment for depression.
As the use of artificial intelligence in R&D continues to rise, Novartis takes it even further, equipping its reps with AI that suggests the perfect things to talk about with HCPs.
The Innovation Authority, the arm of the Israeli government responsible for advancing industrial R&D throughout the country, has given a multi-million-dollar grant to Zebra Medical Vision, a digital health startup.
Two pharma leaders, Eli Lilly and Johnson & Johnson, have begun disclosing product list prices in their TV commercials, taking the plunge that many brands are still approaching nervously.
Tilray, a medical-cannabis producer, has established a new partnership with pharmaceutical giant Novartis, affording the former sales and distribution channels in tens of new countries.
Digital therapeutics, or DTx, are distinct from digital health products, and are driven by software programs that can be prescribed to prevent, manage, or treat a medical disorder or disease, as stated by the Digital Therapeutics Alliance.
Last week, many Amazon Prime members received more than their usual flow of order confirmations and shipping notifications, with the retail leviathan inviting some users to “Meet PillPack, a new member of the Amazon family.”
With plans to enroll as many as 150,000 American senior citizens, Johnson & Johnson is collaborating with Apple on HEARTLINE, a revolutionary new study to detect atrial fibrillation (AFib), a potentially lethal condition that can lead to heart palpitations and stroke.
A $60 million federal program is aiming to bring the benefits of precision medicine to a diverse spread of Wisconsin communities.
Helping modernize the clinical trials process by leaps and bounds, Janssen is undertaking new initiatives to empower research volunteers.
In a new Harvard Business Review article, brand positioning expert Denise Lee Yohn distills some of the most useful marketing points gleaned from her 25 years of marketing leadership.
The producers of As Much As I Can, which just finished its run at NoHo’s Joe’s Pub, are the folks at ViiV Healthcare, a group venture formed by Pfizer, GSK and Shionogi, and they hope their play will help ameliorate the plight of people with HIV.
23andMe, the spit-kit DNA test company that announced a partnership with GSK last year, is embarking on a new health care foray.
At the BrightInsight Ecosystem Event, which explores use cases and best practices in digital health, Harvard Business School Professor Gary Loveman shared some lessons for health care professionals gleaned from his unconventional career path.
Based on data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, one of the largest-ever clinical trials for depression, a startup called Taliaz is helping physicians pick the right antidepressant therapy off the bat.
Facebook is launching Preventive Health, a program designed to make its feed-scrollers the world over more health-conscious, especially when it comes to cancer, heart disease, and the flu.
A New York Times op-ed highlights the problems in American healthcare that are making doctors depressed.
Forget Market Research. | Blog
It’s no surprise that one encounters many veteran journalists in the marketing world: clear and compelling storytelling is invaluable to a brand.
The elimination of CMOs at Johnson & Johnson, Uber and McDonalds highlights how marketing technologies are changing marketing at its core.
For decades, an Alzheimers cure has eluded scientists, who can only recognize the disease once it’s too late.
Pharmaceutical leaders are meeting customers in their AirPods, according to iHeartMedia President Conal Byrne, because audio is a newly critical space for American content consumption.
Though pioneering a brand-new health-monitoring technology, scientists at the Technical University of Munich are doing it through an ancient art: tattoos.
Recognizing that the impact of multiple sclerosis (MS) goes beyond the conventionally recognized symptoms, Sanofi has announced a new app to support people with the disease—specifically, their mental health.
A global alliance of 17 organizations, headed up by the American College of Sports Medicine (ACSM), published a report advising doctors to prescribe exercise to cancer patients.